HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.

Abstract
To evaluate the effect of hypercholesterolemic treatment on coronary artery disease in patients known to be susceptible to disease progression, 44 patients with familial hypercholesterolemia and coronary artery disease were started on a lipid-lowering diet and either probucol (1 g/day) or colestipol (30 g/day). After 5 months of monotherapy, all patients went on a regimen of diet and 2-drug therapy. To date, combination therapy has continued for 3.4 to 4.1 years, and has resulted in the following changes from baseline in mean serum lipid levels: -48.5% in total cholesterol, -53.3% in low density lipoprotein cholesterol, -30.0% in high density lipoprotein cholesterol and +14.5% in triglycerides. The reduction in low density lipoprotein cholesterol apparently improved the clinical status of these patients despite the associated drop in high density lipoprotein cholesterol. In the 19 patients who underwent coronary arteriography before admission to the study, follow-up arteriograms showed that combined treatment stabilized the progression of established lesions and prevented the formation of new ones. Side effects occurred mainly with monotherapy and during the early phase of combination therapy. Reactions included diarrhea, constipation, other vague abdominal symptoms, headache and joint stiffness. In all instances, the side effects gradually subsided after the institution of combination therapy. The combination of probucol and colestipol plus diet appears to be effective in treating most patients with familial hypercholesterolemia.
AuthorsP T Kuo, A C Wilson, J B Kostis, A E Moreyra
JournalThe American journal of cardiology (Am J Cardiol) Vol. 57 Issue 16 Pg. 43H-48H (Jun 27 1986) ISSN: 0002-9149 [Print] United States
PMID3524177 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Phenols
  • Polyamines
  • Triglycerides
  • Cholesterol
  • Colestipol
  • Probucol
Topics
  • Adult
  • Aged
  • Cholesterol (blood)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Clinical Trials as Topic
  • Colestipol (administration & dosage, therapeutic use)
  • Combined Modality Therapy
  • Coronary Disease (blood, diet therapy, drug therapy)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hyperlipoproteinemia Type II (blood, diet therapy, drug therapy)
  • Male
  • Middle Aged
  • Phenols (therapeutic use)
  • Polyamines (therapeutic use)
  • Probucol (administration & dosage, therapeutic use)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: